| Type | Title | Author(s) | Year | Views |
| A Clinicopathologic Analysis of CK19 Expression in Paired Primary and Recurrent/metastatic Hepatocellular CarcinomaProceedings/Conference:APASL 2014 | Lo, CLR; Ng, IOL | 2014 | 6 |
| |
| Blockade of CD47 mediated CTSS-PAR2 signaling provides a therapeutic target for hepatocellular carcinoma | Lee, KW; Cheung, CH; Lu, P; LAU, YT; Ma, SKY; TANG, KH; TONG, M; LO, J; Ng, IOL | 2014 | 3 |
| |
| Proline-rich acidic protein 1 (PRAP1) is a novel interacting partner of MAD1 and has a suppressive role in mitotic checkpoint signalling in hepatocellular carcinoma.Journal:Journal of Pathology Publisher:John Wiley & Sons, Ltd. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/1130 | Sze, MF; Chu, KY; Mak, HY; Lee, MF; Ng, IOL | 2014 | 2 |
| |
| Pathway analysis of genome-wide association data on hepatocellular carcinoma in southern Chinese patients with chronic hepatitis B virus infection.Proceedings/Conference:Joint Conference of HGM 2013 and 21st International Congress of Genetics. | Ho, DWH; Wong, CM; Sham, PC; Ng, IOL | 2013 | 38 |
| |
| EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers | Au, LKS; Wong, CCL; Lee, MF; Wong, CM; Ng, IOL | 2013 | 41 |
| |
| Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patientsJournal:J Natl Cancer Inst | Chew, V; Tow, C; Huang, C; Bard-Chapeau, E; Copeland, NG; Jenkins, NA; Weber, A; Lim, KH; Toh, HC; Heikenwalder, M; Ng, IOL; Nardin, A; Abastado, JP | 2012 | 44 |
| |
| Significance of serum DKK1 as a diagnostic biomarker in hepatocellular carcinoma | Tung, KK; Ng, IOL | 2012 | 31 |
| |
| Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis | Au, LKS; Wong, CCL; Lee, MF; Fan, NY; Tsang, FH; Ng, IOL; Wong, CM | 2012 | 122 |
| |
| The centrosomal protein Tax1 binding protein 2 is a novel tumour suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2 | Lai, WL; Hung, WY; Wong, LLY; Zhou, Y; Leong, VYL; Lee, MF; Ng, IOL; Jin, D; Ching, YP | 2012 | 203 |
| |
| Clinical experience in managing Post Transplant Lymphoproliferative Disease (PTLD) in paediatric patients after liver transplantProceedings/Conference:The 45th Annual Meeting of Pacific Association of Pediatric Surgeons, Shanghai, China, 3-7 June 2012 | Chung, HY; Chan, KL; Chan, IHY; Ng, IOL; Chan, GCF; Chan, SC; Tam, PKH | 2012 | 125 |
| |
| Lysyl oxidase-like 2 is an important determinant of tumor and metastatic niche formation in hepatocellular carcinoma.Proceedings/Conference:Cold Spring Harbor Asia Conference | Wong, CCL; Ng, IOL | 2012 | 67 |
| |
| Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinomaPublisher:Public Library of Science. The Journal's web site is located at http://www.plosone.org/home.action | Lam, CY; Yip, CW; Poon, TCW; Cheng, CKC; Ng, EWY; Wong, NCL; Cheung, PFY; Lai, PBS; Ng, IOL; Fan, ST; Cheung, ST | 2012 | 180 |
| |
| PKA Phosphorylation of Deleted in Liver Cancer 1 (DLC1) at serine-549 modulates its inhibitory activity in liver cancer tumourigenesisProceedings/Conference:The 3rd JCA-AACR Special Joint Conference, Chiba, Japan | Ko, FCF; Chan, LK; Ng, IOL; Yam, JWP | 2011 | 126 |
| |
| Caveolin-1 Promotes Hepatocellular Carcinoma Tumourigenesis, Migration And Invasion Via Met-erk1/2 PathwayProceedings/Conference:Days Of Molecular Medicine, Systems Biology Approaches To Cancer And Metabolic Disease 2010 | Tse, EYT; Ko, FCF; Tung, KK; Chan, LK; Lee, KW; Ngan, ESW; Wong, AST; Ng, IOL; Yam, JWP | 2010 | 2 |
| |
| Endoplasmic storage disease of liver: Characterization of intracytoplasmic hyaline inclusionsPublisher:Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/HIS | Ng, IOL; Lai, ECS; Wu, PC | 1989 | 77 |
| |
